Sale!

GFI1 Gene Neutropenia Severe Congenital Type 2 Autosomal Dominant Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GFI1 Gene Nevere Congenital Neutropenia Type 2 Autosomal Dominant Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE. This test, costing 4400 AED, is designed to identify mutations in the GFI1 gene, which are implicated in the development of Severe Congenital Neutropenia Type 2 (SCN2), an autosomal dominant disorder. SCN2 is characterized by a marked decrease in neutrophil counts, leading to an increased susceptibility to infections from a very young age. The GFI1 gene plays a crucial role in the development and function of neutrophils, and mutations in this gene can disrupt these processes, resulting in the clinical manifestations of SCN2. The test involves the collection of a DNA sample, typically through a blood draw, which is then analyzed for the presence of specific mutations in the GFI1 gene. Identifying these mutations can aid in the diagnosis of SCN2, allowing for the implementation of appropriate treatment and management strategies for affected individuals. DNA Labs UAE offers this genetic testing service as part of their comprehensive suite of diagnostic tools aimed at enhancing patient care through precise genetic insights.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GFI1 Gene Neutropenia severe congenital type 2 autosomal dominant Genetic Test

Are you looking for a reliable genetic lab in UAE to conduct the GFI1 Gene Neutropenia severe congenital type 2 autosomal dominant Genetic Test? Look no further than DNA Labs UAE. Our lab offers comprehensive genetic testing services to help diagnose and manage various genetic disorders.

Test Details

The GFI1 gene is associated with a rare genetic disorder called severe congenital neutropenia type 2 (SCN2). This disorder is inherited in an autosomal dominant manner, which means that a mutation in one copy of the GFI1 gene is enough to cause the condition. Neutropenia refers to a low level of neutrophils, which are a type of white blood cell involved in fighting off infections. In SCN2, individuals have a severe form of neutropenia from birth, which makes them highly susceptible to recurrent bacterial infections.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of genes. In the case of SCN2, NGS genetic testing can be used to identify mutations in the GFI1 gene. This testing can help confirm a diagnosis and determine the specific mutation present in an affected individual or their family members. Knowing the specific mutation can be important for genetic counseling, as it can help predict the likelihood of passing the condition on to future generations. Additionally, it can aid in the development of personalized treatment strategies for individuals with SCN2.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Osteology Dermatology Immunology Disorders

Referring Doctor and Test Department

If you suspect that you or a family member may have GFI1 Gene Neutropenia severe congenital type 2 autosomal dominant, it is recommended to consult a dermatologist. Our test department, Genetics, specializes in genetic testing and can provide you with accurate and reliable results.

Pre Test Information

Before undergoing the GFI1 Gene Neutropenia severe congenital type 2 autosomal dominant NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by GFI1 Gene Neutropenia severe congenital type 2 autosomal dominant.

At DNA Labs UAE, we are committed to providing high-quality genetic testing services. Our team of experts utilizes advanced NGS technology to ensure accurate and reliable results. If you have any questions or would like to schedule a genetic test, please contact us.

Test Name GFI1 Gene Neutropenia severe congenital type 2 autosomal dominant Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GFI1 Gene Neutropenia, severe congenital type 2, autosomal dominant NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GFI1 Gene Neutropenia, severe congenital type 2, autosomal dominant NGS Genetic DNA Test gene GFI1
Test Details

The GFI1 gene is associated with a rare genetic disorder called severe congenital neutropenia type 2 (SCN2). This disorder is inherited in an autosomal dominant manner, which means that a mutation in one copy of the GFI1 gene is enough to cause the condition.

Neutropenia refers to a low level of neutrophils, which are a type of white blood cell involved in fighting off infections. In SCN2, individuals have a severe form of neutropenia from birth, which makes them highly susceptible to recurrent bacterial infections.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of genes. In the case of SCN2, NGS genetic testing can be used to identify mutations in the GFI1 gene. This testing can help confirm a diagnosis and determine the specific mutation present in an affected individual or their family members.

Knowing the specific mutation can be important for genetic counseling, as it can help predict the likelihood of passing the condition on to future generations. Additionally, it can aid in the development of personalized treatment strategies for individuals with SCN2.